+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-invasive Prenatal Testing Market by Component (Consumables & Reagents, Instruments), Test Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection), Gestation Period, Application, End-User - Global Forecast 2025-2030- Product Image
Non-invasive Prenatal Testing Market by Component (Consumables & Reagents, Instruments), Test Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection), Gestation Period, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Non-invasive Prenatal Testing Market by Component (Consumables & Reagents, Instruments), Test Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection), Gestation Period, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968595
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The non-invasive prenatal testing market has rapidly evolved from a niche offering to an essential component of prenatal care, as healthcare providers and laboratory networks integrate advanced technologies to meet the rising demand for accurate, safe, and early fetal screening solutions in diverse global settings.

Market Snapshot: Expanding Non-Invasive Prenatal Testing Market

The non-invasive prenatal testing market grew from USD 7.51 billion in 2024 to USD 8.30 billion in 2025 and is projected to reach USD 13.86 billion by 2030, reflecting a CAGR of 10.74%. Momentum in this sector is driven by increased adoption of cell-free DNA screening, new sequencing technologies, and integration into prenatal protocols globally. Providers must understand the competitive landscape and evolving demand across regions to effectively capitalize on the market’s growth trajectory.

Scope & Segmentation of Non-Invasive Prenatal Testing

  • Component: Consumables & reagents; instruments including microarrays, next-generation sequencing systems, polymerase chain reaction (PCR) instruments, and ultrasound devices
  • Test Method: Biochemical screening tests, cell-free DNA assays in maternal plasma, and ultrasound detection
  • Gestation Period: 10-17 week, 18-23 week, and above 23 week testing windows
  • Application: Microdeletion syndrome screening, sex chromosomal abnormality identification, and trisomy detection
  • End-User: Diagnostic laboratories, hospitals, specialty clinics
  • Geography: Americas (United States - including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, plus Canada, Mexico, Brazil, Argentina) Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland) Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Agilent Technologies, Berry Genomics, BGI Group, BillionToOne, Biora Therapeutics, BioReference Laboratories, Centogene, Eurofins Scientific, F. Hoffmann-La Roche, GE HealthCare Technologies, Igenomix, Illumina, Laboratory Corporation of America, Lilac Insights, MedGenome Labs, Myriad Genetics, Natera, PerkinElmer, Quest Diagnostics, Ravgen, Sonic Healthcare, Thermo Fisher Scientific, Yourgene Health by Novacyt UK Holdings

Key Takeaways for Decision-Makers

  • Non-invasive prenatal testing is now central to early risk assessment and personalized prenatal care, gaining rapid acceptance among healthcare providers and expectant parents alike.
  • Advancements in sequencing technologies and improved bioinformatics have elevated test reliability and shortened the time to actionable clinical insights.
  • Laboratories and hospitals are integrating molecular protocols with ultrasound and biochemical screening to tailor risk profiles and optimize patient management.
  • Demand is distributed across diverse end-user segments: centralized labs scale high volumes, while specialty clinics address complex, high-risk cases.
  • Competition is shaped by R&D investments, automation, and strategic alliances that expand assay portfolios and support regional market entry.
  • Tailored reporting and flexible service delivery models are enhancing satisfaction among hospitals and specialty obstetric practices.

Tariff Impact: Navigating US Policy Changes

With new United States tariff measures introduced in 2025, key inputs such as reagents, sequencing kits, and advanced instruments have become costlier for diagnostic providers. This shift is prompting procurement leaders to diversify sourcing, evaluate nearshoring, and reformulate pricing structures to maintain competitiveness. Strategic collaborations across the value chain—combined with tiered pricing, consolidated purchasing, and alternative distribution—are helping the industry address the new cost landscape and continue expanding adoption.

Methodology & Data Sources

This report combines extensive literature reviews from peer-reviewed journals, white papers, and clinical guidelines with primary interviews and structured surveys of opinion leaders, laboratory directors, and administrators. Systematic triangulation and trend analysis ensure robust, actionable insights for all stakeholder groups.

Why This Report Matters

  • Offers concise, evidence-backed guidance for shaping investment, partnership, and innovation strategies in the non-invasive prenatal testing market.
  • Enables executives to understand shifting supply chain, technology, and payer dynamics across regions and end-user categories.
  • Provides decision-makers with a comprehensive overview to optimize market positioning and align offerings with clinical and regulatory needs.

Conclusion

Non-invasive prenatal testing continues to transform prenatal care pathways and stakeholder collaboration. By leveraging robust market knowledge and staying agile, organizations can strengthen their market presence and deliver lasting value to clinicians and patients.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of AI-driven bioinformatics pipelines to enhance variant interpretation and reduce NIPT false positive rates
5.2. Expansion of NIPT panels to include rare microdeletions and single gene disorder screening for comprehensive prenatal risk assessment
5.3. Adoption of novel sample collection methods enabling at-home NIPT testing with smartphone-compatible mobile phlebotomy units
5.4. Integration of polygenic risk scoring into non-invasive prenatal tests to assess multifactorial disease predisposition in fetuses
5.5. Strategic partnerships between sequencing technology firms and diagnostic laboratories to accelerate NIPT assay development pipelines
5.6. Policy and reimbursement landscape shifts influencing NIPT adoption in public healthcare systems across North America and Europe
5.7. Development of non-blood based NIPT assays using maternal saliva or urine samples for simplified fetal DNA extraction workflows
5.8. Emergence of direct-to-consumer NIPT platforms offering at-home collection kits and virtual genetic counseling services
5.9. Ethical and regulatory frameworks evolving to address incidental findings and data privacy concerns in expanded NIPT portfolios
5.10. Adoption of molecular barcode enrichment strategies to reduce sequencing costs and improve analytical sensitivity of NIPT assays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-invasive Prenatal Testing Market, by Component
8.1. Introduction
8.2. Consumables & Reagents
8.3. Instruments
8.3.1. Microarrays
8.3.2. Next-Generation Sequencing Systems
8.3.3. Polymerase Chain Reaction Instruments
8.3.4. Ultrasound Devices
9. Non-invasive Prenatal Testing Market, by Test Method
9.1. Introduction
9.2. Biochemical Screening Tests
9.3. Cell-free DNA in Maternal Plasma Tests
9.4. Ultrasound Detection
10. Non-invasive Prenatal Testing Market, by Gestation Period
10.1. Introduction
10.2. 10-17 Week
10.3. 18-23 Week
10.4. Above 23 Week
11. Non-invasive Prenatal Testing Market, by Application
11.1. Introduction
11.2. Microdeletion Syndrome
11.3. Sex Chromosomal Abnormalities
11.4. Trisomy
12. Non-invasive Prenatal Testing Market, by End-User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Specialty Clinics
13. Americas Non-invasive Prenatal Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Non-invasive Prenatal Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Non-invasive Prenatal Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Agilent Technologies, Inc.
16.3.2. Berry Genomics Co. Ltd.
16.3.3. BGI Group
16.3.4. BillionToOne, Inc.
16.3.5. Biora Therapeutics, Inc.
16.3.6. BioReference Laboratories, Inc.
16.3.7. Centogene N.V.
16.3.8. Eurofins Scientific (Ireland) Limited
16.3.9. F.Hoffmann-La Roche Ltd.
16.3.10. GE HealthCare Technologies Inc.
16.3.11. Igenomix S.L.U
16.3.12. Illumina, Inc.
16.3.13. Laboratory Corporation of America Holdings
16.3.14. Lilac Insights Pvt. Ltd.
16.3.15. MedGenome Labs Ltd.
16.3.16. Myriad Genetics, Inc.
16.3.17. Natera, Inc.
16.3.18. PerkinElmer Inc.
16.3.19. Quest Diagnostics Incorporated
16.3.20. Ravgen Inc.
16.3.21. Sonic Healthcare USA
16.3.22. Thermo Fisher Scientific Inc.
16.3.23. Yourgene Health by Novacyt UK Holdings Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NON-INVASIVE PRENATAL TESTING MARKET: RESEARCHAI
FIGURE 26. NON-INVASIVE PRENATAL TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. NON-INVASIVE PRENATAL TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. NON-INVASIVE PRENATAL TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOMAL ABNORMALITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOMAL ABNORMALITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 86. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 87. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 88. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 89. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 90. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 91. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 92. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 93. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 98. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 99. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 102. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 103. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 104. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 105. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 160. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 161. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 164. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 165. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 166. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 167. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 172. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 173. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 176. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 177. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 178. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 179. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 196. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 197. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 200. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 201. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 202. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 203. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 208. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 209. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 212. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 213. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 214. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 215. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 256. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 257. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 260. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 261. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 262. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 263. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 280. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 281. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 282. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 283. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 284. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 285. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 286. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 287. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 292. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 293. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 296. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 297. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 298. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 299. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST METHOD, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • Agilent Technologies, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Group
  • BillionToOne, Inc.
  • Biora Therapeutics, Inc.
  • BioReference Laboratories, Inc.
  • Centogene N.V.
  • Eurofins Scientific (Ireland) Limited
  • F.Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Igenomix S.L.U
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Lilac Insights Pvt. Ltd.
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.
  • Sonic Healthcare USA
  • Thermo Fisher Scientific Inc.
  • Yourgene Health by Novacyt UK Holdings Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.86 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Non-Invasive Prenatal DNA Testing Service Market by Application, Technology, End User, Distribution Channel, Service Model, Sample Type - Global Forecast 2025-2030 - Product Image

Non-Invasive Prenatal DNA Testing Service Market by Application, Technology, End User, Distribution Channel, Service Model, Sample Type - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Non-invasive Prenatal Genetic Testing Market by Product Type (Reagent Kits, Services), Technology (Microarray, Ngs, Qpcr), Indication, End User, Application, Testing Approach - Global Forecast 2025-2030 - Product Image

Non-invasive Prenatal Genetic Testing Market by Product Type (Reagent Kits, Services), Technology (Microarray, Ngs, Qpcr), Indication, End User, Application, Testing Approach - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Non-Invasive Prenatal Testing (NIPT) Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034) - Product Image

Non-Invasive Prenatal Testing (NIPT) Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Prenatal Diagnostics - Global Strategic Business Report - Product Image

Prenatal Diagnostics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.